---
schema_version: "secwatch.filing_event.v1"
accession: "0001104659-26-062536"
form_type: "8-K"
ticker: "COLL"
cik: "0001267565"
company_name: "COLLEGIUM PHARMACEUTICAL, INC"
filed_at: "2026-05-15T20:10:34+00:00"
generated_at: "2026-05-15T20:17:21.227748+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.25
calibrated_materiality_score: 0.15
confidence: "high"
source: SEC EDGAR
---

# Collegium shareholders elect all eight director nominees, approve say-on-pay, ratify Deloitte

## Summary
- All eight director nominees elected with 25.9M to 27.4M votes for each; broker non-votes 1.79M.
- Advisory vote on executive compensation approved: 26.3M for, 1.1M against, 5.6K abstentions.
- Ratification of Deloitte & Touche as auditor for FY 2026 passed: 28.95M for, 252.8K against.
- Meeting held May 14, 2026; 29.2M of 32.4M shares present in person or by proxy.

## SEC filing metadata
- accession: 0001104659-26-062536
- form_type: 8-K
- ticker: COLL
- cik: 0001267565
- company_name: COLLEGIUM PHARMACEUTICAL, INC
- filed_at: 2026-05-15T20:10:34+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.25
- calibrated_materiality_score: 0.15
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1267565/000110465926062536/0001104659-26-062536-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1267565/000110465926062536/tm2614189d1_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001104659-26-062536
- JSON: https://secwatch.observer/filing/0001104659-26-062536.json
- Plain text: https://secwatch.observer/filing/0001104659-26-062536.txt

## Key facts
- Shareholder Votes
  COLLEGIUM PHARMACEUTICAL, INC shareholders approved Election of eight Directors to hold office until the 2027 Annual Meeting of Shareholders at the 2026-05-14 meeting.
  - Proposal: director election
  - Outcome: passed
  - Meeting: 2026-05-14
  source text: PROPOSAL 1 : Election of eight Directors to hold office until the 2027 Annual Meeting of Shareholders.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1267565/000110465926062536/0001104659-26-062536-index.htm
- Shareholder Votes
  COLLEGIUM PHARMACEUTICAL, INC shareholders approved Approval of, on an advisory basis, the compensation of the Company's named executive officers at the 2026-05-14 meeting.
  - Proposal: say on pay
  - Outcome: passed
  - Meeting: 2026-05-14
  source text: PROPOSAL 2: Approval of, on an advisory basis, the compensation of the Company’s named executive officers.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1267565/000110465926062536/0001104659-26-062536-index.htm
- Shareholder Votes
  COLLEGIUM PHARMACEUTICAL, INC shareholders approved Ratification of the appointment of Deloitte & Touche LLP as the Company's independent registered public accounting firm for the fiscal year ending December 31, 2026 at the 2026-05-14 meeting.
  - Proposal: auditor ratification
  - Outcome: passed
  - Meeting: 2026-05-14
  source text: PROPOSAL 3 : Ratification of the appointment of Deloitte & Touche LLP as the Company’s independent registered public accounting firm for the fiscal year ending December 31, 2026.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1267565/000110465926062536/0001104659-26-062536-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.